Global Pharmaceutical Single Dose Packaging Market Growth 2025-2031

Publication ID:

LPI06252816

Publication Date:

June 30, 2025

Pages:

105

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Packaging Machinery [2]

Packaging [3]

Industry & Manufacturing [4]

Description:

The global Pharmaceutical Single Dose Packaging market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淧harmaceutical Single Dose Packaging Industry Forecast鈥� looks at past sales and reviews total world Pharmaceutical Single Dose Packaging sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Single Dose Packaging sales for 2025 through 2031. With Pharmaceutical Single Dose Packaging sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Single Dose Packaging industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Single Dose Packaging landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Single Dose Packaging portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Pharmaceutical Single Dose Packaging market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Single Dose Packaging and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Single Dose Packaging.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Single Dose Packaging market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Prefilled Syringes Cartridges
Prefilled Syringes Cartridges
Vials Pharmaceutical Unit Dose Packaging
Ampoules Pharmaceutical Unit Dose Packaging
Blisters Pharmaceutical Unit Dose Packaging
Others
Segmentation by Application:
Orals
Respiratory Therapy
Wound Care
Biologics
Injectable
Ophthalmic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Pfizer Inc.
Johnson & Johnson
Merck & Co. Inc.
Bristol-Myers Squibb Company
AbbVie Inc.
UDG Healthcare plc
Comar LLC
Berry Global
Gerresheimer AG
Amcor plc
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pharmaceutical Single Dose Packaging market?
What factors are driving Pharmaceutical Single Dose Packaging market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pharmaceutical Single Dose Packaging market opportunities vary by end market size?
How does Pharmaceutical Single Dose Packaging break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharmaceutical Single Dose Packaging Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Pharmaceutical Single Dose Packaging by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Pharmaceutical Single Dose Packaging by Country/Region, 2020, 2024 & 2031
2.2 Pharmaceutical Single Dose Packaging Segment by Type
2.2.1 Prefilled Syringes Cartridges
2.2.2 Prefilled Syringes Cartridges
2.2.3 Vials Pharmaceutical Unit Dose Packaging
2.2.4 Ampoules Pharmaceutical Unit Dose Packaging
2.2.5 Blisters Pharmaceutical Unit Dose Packaging
2.2.6 Others
2.3 Pharmaceutical Single Dose Packaging Sales by Type
2.3.1 Global Pharmaceutical Single Dose Packaging Sales Market Share by Type (2020-2025)
2.3.2 Global Pharmaceutical Single Dose Packaging Revenue and Market Share by Type (2020-2025)
2.3.3 Global Pharmaceutical Single Dose Packaging Sale Price by Type (2020-2025)
2.4 Pharmaceutical Single Dose Packaging Segment by Application
2.4.1 Orals
2.4.2 Respiratory Therapy
2.4.3 Wound Care
2.4.4 Biologics
2.4.5 Injectable
2.4.6 Ophthalmic
2.4.7 Others
2.5 Pharmaceutical Single Dose Packaging Sales by Application
2.5.1 Global Pharmaceutical Single Dose Packaging Sale Market Share by Application (2020-2025)
2.5.2 Global Pharmaceutical Single Dose Packaging Revenue and Market Share by Application (2020-2025)
2.5.3 Global Pharmaceutical Single Dose Packaging Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Pharmaceutical Single Dose Packaging Breakdown Data by Company
3.1.1 Global Pharmaceutical Single Dose Packaging Annual Sales by Company (2020-2025)
3.1.2 Global Pharmaceutical Single Dose Packaging Sales Market Share by Company (2020-2025)
3.2 Global Pharmaceutical Single Dose Packaging Annual Revenue by Company (2020-2025)
3.2.1 Global Pharmaceutical Single Dose Packaging Revenue by Company (2020-2025)
3.2.2 Global Pharmaceutical Single Dose Packaging Revenue Market Share by Company (2020-2025)
3.3 Global Pharmaceutical Single Dose Packaging Sale Price by Company
3.4 Key Manufacturers Pharmaceutical Single Dose Packaging Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pharmaceutical Single Dose Packaging Product Location Distribution
3.4.2 Players Pharmaceutical Single Dose Packaging Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Pharmaceutical Single Dose Packaging by Geographic Region
4.1 World Historic Pharmaceutical Single Dose Packaging Market Size by Geographic Region (2020-2025)
4.1.1 Global Pharmaceutical Single Dose Packaging Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Pharmaceutical Single Dose Packaging Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pharmaceutical Single Dose Packaging Market Size by Country/Region (2020-2025)
4.2.1 Global Pharmaceutical Single Dose Packaging Annual Sales by Country/Region (2020-2025)
4.2.2 Global Pharmaceutical Single Dose Packaging Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pharmaceutical Single Dose Packaging Sales Growth
4.4 APAC Pharmaceutical Single Dose Packaging Sales Growth
4.5 Europe Pharmaceutical Single Dose Packaging Sales Growth
4.6 Middle East & Africa Pharmaceutical Single Dose Packaging Sales Growth
5 Americas
5.1 Americas Pharmaceutical Single Dose Packaging Sales by Country
5.1.1 Americas Pharmaceutical Single Dose Packaging Sales by Country (2020-2025)
5.1.2 Americas Pharmaceutical Single Dose Packaging Revenue by Country (2020-2025)
5.2 Americas Pharmaceutical Single Dose Packaging Sales by Type (2020-2025)
5.3 Americas Pharmaceutical Single Dose Packaging Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Single Dose Packaging Sales by Region
6.1.1 APAC Pharmaceutical Single Dose Packaging Sales by Region (2020-2025)
6.1.2 APAC Pharmaceutical Single Dose Packaging Revenue by Region (2020-2025)
6.2 APAC Pharmaceutical Single Dose Packaging Sales by Type (2020-2025)
6.3 APAC Pharmaceutical Single Dose Packaging Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pharmaceutical Single Dose Packaging by Country
7.1.1 Europe Pharmaceutical Single Dose Packaging Sales by Country (2020-2025)
7.1.2 Europe Pharmaceutical Single Dose Packaging Revenue by Country (2020-2025)
7.2 Europe Pharmaceutical Single Dose Packaging Sales by Type (2020-2025)
7.3 Europe Pharmaceutical Single Dose Packaging Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmaceutical Single Dose Packaging by Country
8.1.1 Middle East & Africa Pharmaceutical Single Dose Packaging Sales by Country (2020-2025)
8.1.2 Middle East & Africa Pharmaceutical Single Dose Packaging Revenue by Country (2020-2025)
8.2 Middle East & Africa Pharmaceutical Single Dose Packaging Sales by Type (2020-2025)
8.3 Middle East & Africa Pharmaceutical Single Dose Packaging Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pharmaceutical Single Dose Packaging
10.3 Manufacturing Process Analysis of Pharmaceutical Single Dose Packaging
10.4 Industry Chain Structure of Pharmaceutical Single Dose Packaging
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pharmaceutical Single Dose Packaging Distributors
11.3 Pharmaceutical Single Dose Packaging Customer
12 World Forecast Review for Pharmaceutical Single Dose Packaging by Geographic Region
12.1 Global Pharmaceutical Single Dose Packaging Market Size Forecast by Region
12.1.1 Global Pharmaceutical Single Dose Packaging Forecast by Region (2026-2031)
12.1.2 Global Pharmaceutical Single Dose Packaging Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pharmaceutical Single Dose Packaging Forecast by Type (2026-2031)
12.7 Global Pharmaceutical Single Dose Packaging Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Pfizer Inc.
13.1.1 Pfizer Inc. Company Information
13.1.2 Pfizer Inc. Pharmaceutical Single Dose Packaging Product Portfolios and Specifications
13.1.3 Pfizer Inc. Pharmaceutical Single Dose Packaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Pfizer Inc. Main Business Overview
13.1.5 Pfizer Inc. Latest Developments
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Information
13.2.2 Johnson & Johnson Pharmaceutical Single Dose Packaging Product Portfolios and Specifications
13.2.3 Johnson & Johnson Pharmaceutical Single Dose Packaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Johnson & Johnson Main Business Overview
13.2.5 Johnson & Johnson Latest Developments
13.3 Merck & Co. Inc.
13.3.1 Merck & Co. Inc. Company Information
13.3.2 Merck & Co. Inc. Pharmaceutical Single Dose Packaging Product Portfolios and Specifications
13.3.3 Merck & Co. Inc. Pharmaceutical Single Dose Packaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Merck & Co. Inc. Main Business Overview
13.3.5 Merck & Co. Inc. Latest Developments
13.4 Bristol-Myers Squibb Company
13.4.1 Bristol-Myers Squibb Company Company Information
13.4.2 Bristol-Myers Squibb Company Pharmaceutical Single Dose Packaging Product Portfolios and Specifications
13.4.3 Bristol-Myers Squibb Company Pharmaceutical Single Dose Packaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Bristol-Myers Squibb Company Main Business Overview
13.4.5 Bristol-Myers Squibb Company Latest Developments
13.5 AbbVie Inc.
13.5.1 AbbVie Inc. Company Information
13.5.2 AbbVie Inc. Pharmaceutical Single Dose Packaging Product Portfolios and Specifications
13.5.3 AbbVie Inc. Pharmaceutical Single Dose Packaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 AbbVie Inc. Main Business Overview
13.5.5 AbbVie Inc. Latest Developments
13.6 UDG Healthcare plc
13.6.1 UDG Healthcare plc Company Information
13.6.2 UDG Healthcare plc Pharmaceutical Single Dose Packaging Product Portfolios and Specifications
13.6.3 UDG Healthcare plc Pharmaceutical Single Dose Packaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 UDG Healthcare plc Main Business Overview
13.6.5 UDG Healthcare plc Latest Developments
13.7 Comar LLC
13.7.1 Comar LLC Company Information
13.7.2 Comar LLC Pharmaceutical Single Dose Packaging Product Portfolios and Specifications
13.7.3 Comar LLC Pharmaceutical Single Dose Packaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Comar LLC Main Business Overview
13.7.5 Comar LLC Latest Developments
13.8 Berry Global
13.8.1 Berry Global Company Information
13.8.2 Berry Global Pharmaceutical Single Dose Packaging Product Portfolios and Specifications
13.8.3 Berry Global Pharmaceutical Single Dose Packaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Berry Global Main Business Overview
13.8.5 Berry Global Latest Developments
13.9 Gerresheimer AG
13.9.1 Gerresheimer AG Company Information
13.9.2 Gerresheimer AG Pharmaceutical Single Dose Packaging Product Portfolios and Specifications
13.9.3 Gerresheimer AG Pharmaceutical Single Dose Packaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Gerresheimer AG Main Business Overview
13.9.5 Gerresheimer AG Latest Developments
13.10 Amcor plc
13.10.1 Amcor plc Company Information
13.10.2 Amcor plc Pharmaceutical Single Dose Packaging Product Portfolios and Specifications
13.10.3 Amcor plc Pharmaceutical Single Dose Packaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Amcor plc Main Business Overview
13.10.5 Amcor plc Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂